Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Active Biotech AB ( (SE:ACTI) ) has provided an update.
Active Biotech AB has announced its Annual General Meeting (AGM) scheduled for May 28, 2025, in Lund, Sweden. Key agenda items include the re-election of board members and the decision to carry forward the company’s accumulated loss without paying dividends. The AGM will also address the re-election of Öhrlings PricewaterhouseCoopers AB as the company’s auditor, with no changes to the board’s remuneration.
More about Active Biotech AB
Active Biotech AB is a Swedish company operating in the biotechnology industry, focusing on the development of pharmaceuticals for the treatment of diseases with significant unmet medical needs.
YTD Price Performance: -21.43%
Average Trading Volume: 26,358
Technical Sentiment Signal: Strong Buy
Current Market Cap: €9.72M
Learn more about ACTI stock on TipRanks’ Stock Analysis page.